Streetbeat News

Earnings

SYRS

Syros Pharmaceuticals (NASDAQ:SYRS) is expected to release its quarterly earnings report on Tuesday, 2023-11-14, with an estimated EPS of $-1.14. Investors are looking for an earnings beat and positive guidance for the next quarter. Historically, the company's stock price has been affected more by guidance than by earnings beats or misses. Last quarter, SYRS missed the EPS estimate by $0.17, resulting in a 1.91% increase in share price the following day. Over the last year, SYRS shares have declined by 30.17%, indicating a bearish sentiment among long-term shareholders.

Portfolio Pulse from Benzinga Insights

November 13, 2023 | 3:02 pm

ASXC

Asensus Surgical (AMEX:ASXC) is expected to release its quarterly earnings report on Tuesday, 2023-11-14, with analysts predicting an EPS of $-0.07. Investors are looking for an earnings beat and positive guidance for future growth. Historically, Asensus Surgical's stock price has reacted variably to earnings reports, with both increases and decreases in share price following announcements. Currently, the stock is trading at $0.21, down 55.91% over the last 52 weeks. The upcoming earnings report could influence the stock's performance, especially if the company provides strong future guidance.

Portfolio Pulse from Benzinga Insights

November 13, 2023 | 3:01 pm

IMNN

Imunon (NASDAQ:IMNN) is expected to release its quarterly earnings report on Tuesday, 2023-11-14, with an estimated EPS of $-0.66. Investors are looking for an earnings beat and positive guidance for the next quarter. Historically, Imunon's stock price has shown mixed reactions to earnings reports, with a 4.13% drop after beating EPS last quarter. Over the past 52 weeks, IMNN shares have declined by 37.16%, indicating a bearish sentiment among long-term shareholders.

Portfolio Pulse from Benzinga Insights

November 13, 2023 | 3:01 pm

PDSB

PDS Biotechnology (NASDAQ:PDSB) is scheduled to release its quarterly earnings report on Tuesday, 2023-11-14, with analysts expecting an EPS of $-0.45. Investors are looking for an earnings beat and positive guidance for the next quarter. In the past, PDSB's stock price has been influenced more by guidance than earnings beats or misses. Last quarter, PDSB met the EPS estimate, resulting in a 10.32% stock price increase the following day. Over the last year, PDSB shares have declined by 40.38%, indicating potential concern among long-term shareholders ahead of the earnings release.

Portfolio Pulse from Benzinga Insights

November 13, 2023 | 3:01 pm

URGN

UroGen Pharma (NASDAQ:URGN) is expected to release its quarterly earnings report on Tuesday, 2023-11-14, with an estimated EPS of $-0.85. Investors are looking for a beat on this estimate and positive guidance for future growth. Historically, URGN's stock price has been sensitive to earnings performance and guidance. Last quarter, URGN beat the EPS estimate by $0.11, leading to a 4.48% stock price increase the following day. Over the last year, URGN shares have risen by 25.99%, indicating a bullish sentiment among long-term shareholders.

Portfolio Pulse from Benzinga Insights

November 13, 2023 | 3:01 pm

GRTX

Galera Therapeutics (NASDAQ:GRTX) is expected to release its quarterly earnings report on Tuesday, 2023-11-14, with an estimated EPS of $-0.40. Investors are looking for an earnings beat and positive guidance for the next quarter. Historically, GRTX's stock price has been sensitive to earnings performance, with a 10.03% drop after missing EPS last quarter. Over the past year, GRTX shares have declined by 92.8%, indicating a bearish sentiment among long-term shareholders.

Portfolio Pulse from Benzinga Insights

November 13, 2023 | 3:01 pm

NGS

Natural Gas Services Gr (NYSE:NGS) is expected to release its quarterly earnings report on Tuesday, 2023-11-14, with analysts estimating an EPS of $0.07. Investors are looking for an earnings beat and positive guidance for future growth. Historically, NGS's stock price has been sensitive to earnings performance and guidance. Last quarter, NGS beat the EPS estimate by $0.12, resulting in a 3.96% stock price increase the following day. Over the last year, NGS shares have risen by 26.64%, indicating a bullish sentiment among long-term shareholders.

Portfolio Pulse from Benzinga Insights

November 13, 2023 | 3:01 pm

KSCP

Knightscope (NASDAQ:KSCP) reported Q3 earnings with an EPS of $-0.11, missing estimates by 22.22% compared to the expected $-0.09. Revenue increased by $2.03 million from the same period last year. Despite beating EPS estimates last quarter, the stock price fell by 6.38% the following day.

Portfolio Pulse from Benzinga Insights

November 13, 2023 | 3:00 pm

NFLX

Netflix Inc's stock (NFLX) has seen a significant rise following its Q3 earnings report, with a 16% increase post-announcement and a 28% rise since then. The stock faces resistance at the $500 mark and last year's high of $609. Despite a previous drop below the 200 daily simple moving average, the stock found support around the weekly 50 simple moving average. The positive earnings, driven by subscriber growth, have contributed to the stock's upward trend, with an 8% increase in November alone.

Portfolio Pulse from Zaheer Anwari

November 13, 2023 | 2:52 pm

DISH

LSXMK

NCMI

TGNA

WB

The article discusses value stocks in the communication services sector, highlighting companies with low P/E ratios. Weibo (WB) saw an EPS increase from $0.53 to $0.57. Tegna (TGNA) experienced a decrease in EPS from $0.44 to $0.39 but increased its dividend yield. DISH Network (DISH) reported a decrease in EPS from $0.31 to $-0.26. Liberty SiriusXM Gr (LSXMK) reported a significant increase in EPS from $0.08 to $0.89. National CineMedia (NCMI) saw an EPS increase from $-0.70 to $-0.34 and a dividend yield increase.

Portfolio Pulse from Benzinga Insights

November 13, 2023 | 2:45 pm